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Staphylococcus aureus is the leading cause of blood-
stream, lower respiratory tract, skin, and soft 
tissue infections (Klevens et al., 2006; Klevens 
et al., 2007) because of its unique ability to 
multiply  in  blood  or  other  host  tissues  and 
cause persistent infections (Lowy, 1998). To 
survive in blood, S. aureus must escape a variety 
of innate immune mechanisms, such as antimi-
crobial peptides, complement, and phagocytic 
killing (Foster, 2005; Peschel and Sahl, 2006). 
An immediate and essential host defense against 
S.  aureus  is  provided  by  neutrophilic  PMNs 
(neutrophils), which comprise 60–70% of hu-
man white blood cells (Voyich et al., 2005). 
Staphylococci deploy a plethora of mechanisms 
aimed  at  subverting  innate  immune  mecha-
nisms, including secretion of factors inhibitory 
for complement activation and neutrophil che-
motaxis (de Haas et al., 2004; Rooijakkers et al., 
2005), as well as toxins that lyse neutrophils 
(Wang et al., 2007), neutralize antimicrobial 
defensins (Jin et al., 2004), or act as superanti-
gens to inappropriately activate the host’s im-
mune system (Jardetzky et al., 1994). In this 
paper, we report the discovery of a hitherto 
unknown strategy: synthesis of the immuno-
suppressive signaling molecule adenosine.
In mammals, adenosine assumes an essential 
role in regulating innate and acquired immune 
responses (Thiel et al., 2003). Strong or excessive 
host inflammatory responses, e.g., in response 
to bacterial infection, exacerbate the tissue damage 
inflicted by invading pathogens (Thiel et al., 
2003). Successful immune clearance of microbes 
therefore involves the balancing of pro- and anti-
inflammatory mediators. The cytokines IL-4, 
IL-10, IL-13, and TGF- play a role in restrict-
ing excessive inflammation, but only adenosine 
is able to completely suppress immune responses 
(Németh et al., 2006). The immunoregulatory 
attributes of adenosine are mediated via four 
transmembrane adenosine receptors: A1, A2A, 
A2B, and A3 (Haskó and Pacher, 2008). T lym-
phocytes express the high affinity A2A receptor 
as well as the low affinity A2B receptor (Thiel   
et al., 2003). Depending on their activation state, 
macrophages and neutrophils express all four 
adenosine receptors, whereas B cells harbor only 
A2A (Thiel et al., 2003). Engagement of A2A  
inhibits IL-12 production, increases IL-10 in 
monocytes (Khoa et al., 2001) and dendritic 
cells (Panther et al., 2001), and decreases cyto-
toxic attributes and chemokine production in 
neutrophils (Cronstein et al., 1986; McColl   
et al., 2006). Generation of adenosine at sites of 
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Staphylococcus aureus infects hospitalized or healthy individuals and represents the most 
frequent cause of bacteremia, treatment of which is complicated by the emergence of 
methicillin-resistant S. aureus. We examined the ability of S. aureus to escape phagocytic 
clearance in blood and identified adenosine synthase A (AdsA), a cell wall–anchored 
enzyme that converts adenosine monophosphate to adenosine, as a critical virulence 
factor. Staphylococcal synthesis of adenosine in blood, escape from phagocytic clearance, 
and subsequent formation of organ abscesses were all dependent on adsA and could be 
rescued by an exogenous supply of adenosine. An AdsA homologue was identified in the 
anthrax pathogen, and adenosine synthesis also enabled escape of Bacillus anthracis from 
phagocytic clearance. Collectively, these results suggest that staphylococci and other 
bacterial pathogens exploit the immunomodulatory attributes of adenosine to escape 
host immune responses.
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of adenosine from 5-AMP. To further examine the impor-
tance of adsA in staphylococcal virulence, we complemented 
the adsA gene by cloning the entire adsA gene and upstream 
promoter sequences into expression vector pOS1, generating 
padsA.  Transformation  of  adsA  mutant  staphylococci  with 
padsA restored their ability to survive in mouse or rat blood, 
indicating that the observed virulence defect is indeed caused 
by the absence of adsA expression (Fig. 1, C and F; see Fig. 3 C 
for confirmation of AdsA expression). S. aureus survival was 
also examined in the blood of human volunteers. Similar to 
mouse blood, the number of adsA mutant staphylococci was 
reduced as compared with wild-type S. aureus Newman, and 
this defect was restored by transformation of adsA mutants 
with padsA (Fig. 1 G).
AdsA is required for staphylococci virulence  
and abscess formation
To investigate the contribution of adsA to invasive staphylo-
coccal disease, BALB/c mice were infected by intravenous in-
oculation with 107 CFU of wild-type S. aureus Newman or its 
isogenic adsA variant. Animals were killed 5 d after infection 
and both kidneys were removed. The right kidney was ho-
mogenized, and staphylococcal load was enumerated by plat-
ing on agar and colony formation (Fig. 2 A). The left kidney 
was fixed with formalin, embedded in paraffin, thin sectioned, 
and analyzed for histopathology (Fig. 2 B). As expected, wild-
type S. aureus Newman formed abscesses in kidneys with a 
mean bacterial load of 3 × 107 CFU per gram of tissue. In 
contrast, adsA mutant staphylococci were unable to form ab-
scesses and displayed a >10-fold reduction in bacterial load as 
compared with the wild type (P < 0.03; Fig. 2, A and B).
Staphylococcal strains that cause community-acquired 
methicillin-resistant Staphylococcus aureus (CA-MRSA) have 
been characterized by pulsed-field gel electrophoresis and 
DNA sequencing. Currently, the major CA-MRSA clone is 
USA300 (McDougal et al., 2003), the predominant cause of 
skin and soft tissue infections as well as bacteremia (Carleton 
et al., 2004). To assess the contribution of adsA toward viru-
lence of USA300, we isolated an isogenic adsA mutant using 
phage transduction and S. aureus strain LAC (USA300; Bae 
et al., 2004). BALB/c mice were infected by intravenous injec-
tion of 107 CFU. 5 d after challenge, staphylococci were 
enumerated in homogenized kidney tissue and histopathol-
ogy was visualized in hematoxylin-eosin–stained thin sec-
tions (Fig. 2 C). Similar to S. aureus Newman, we observed a 
1-log reduction in CFUs recovered from the kidneys of ani-
mals infected with the adsA mutant of S. aureus USA300. 
Further, we observed fewer abscesses and smaller lesions in 
the kidneys of mice infected with the adsA variant (Fig. 2 D 
and Fig. S1). Collectively, these results suggest a significant 
contribution of adsA toward virulence of two clinical isolates, 
S. aureus strains Newman and USA300.
Differences in abscess formation and recovery of CFUs 
from the kidneys of infected mice may stem from enhanced 
bacterial clearance in the blood stream, causing fewer bacteria 
to reach peripheral organ tissues. Alternatively, adsA could 
inflammation, hypoxia, organ injury, and traumatic shock is 
mediated by two sequential enzymes. Ecto-ATP diphos-
phohydrolase (CD39) converts circulating ATP and ADP 
to AMP (Eltzschig et al., 2003). CD73, expressed on the 
surface of endothelial cells (Deussen et al., 1993) and subsets 
of T cells (Thompson et al., 1987; Thompson et al., 1989; 
Yang  et  al.,  2005),  then  converts  5-AMP  to  adenosine 
(Zimmermann, 1992).
Although extracellular adenosine is essential for the sup-
pression of inflammation, build-up of excess adenosine is also 
detrimental. This is exemplified in patients with a deficiency 
in adenosine deaminase, an enzyme that converts adenosine 
to inosine (Giblett et al., 1972). Adenosine deaminase defi-
ciency causes severe compromised immunodeficiency syn-
drome, with impaired cellular immunity and severely decreased 
production of immunoglobulins (Buckley et al., 1997). As 
the regulation of extracellular adenosine is critical in main-
taining  immune  homeostasis,  perturbation  of  adenosine 
levels is likely to affect host immune responses during infec-
tion. We report in this paper that S. aureus and Bacillus anthracis, 
the causative agent of anthrax, use adenosine synthesis to 
escape host immune responses.
RESULTS
Adenosine synthase A (AdsA) is required for staphylococcal 
survival in blood
To identify the staphylococcal genes required for escape from 
innate immune responses, we examined the ability of S. aureus 
strain  Newman  to  survive  in  whole  blood  collected  from 
BALB/c mice or Sprague-Dawley rats by recording bacterial 
load at timed intervals via the formation of colonies on agar 
medium (Fig. 1). As expected, the blood of naive mice and 
rats, which lack antibodies specific for staphylococci (not de-
picted), were unable to kill S. aureus Newman (Fig. 1, A and D). 
In contrast to the wild-type strain, a variant lacking the struc-
tural gene for sortase A (srtA) displayed a defect in staphylo-
coccal escape from phagocytic killing (P < 0.05; Fig. 1, A and D).   
Sortase A anchors a large spectrum of different polypeptides 
in  the  staphylococcal  envelope,  using  a  transpeptidation 
mechanism and LPXTG motif sorting signal at the C terminus 
of surface proteins (Mazmanian et al., 2002). To examine 
these surface proteins for their contribution to staphylococcal 
survival in blood, we transduced bursa aurealis insertions in sur-
face protein genes (Bae et al., 2004) into wild-type strain S. 
aureus Newman and measured the survival of staphylococcal 
variants in blood (Fig. 1, B and E). Mutations in clfA and sasH 
(Staphylococcus aureus surface protein), hereafter named adsA, 
displayed consistent survival defects. The phenotype of clfA 
mutants represents an expected result, as the encoded clump-
ing factor A product is known to precipitate fibrin and inter-
fere with macrophage and neutrophil phagocytosis (Palmqvist 
et al., 2004; Higgins et al., 2006). The contribution of AdsA 
to pathogenesis is not yet known. AdsA harbors a 5-nucleo-
tidase domain with the two signature sequences ILHTnDiH-
GrL (residues 124–134) and YdamaVGNHEFD (residues 
189–201), suggesting that the protein may catalyze the synthesis JEM VOL. 206, October 26, 2009 
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AdsA in the staphylococcal envelope was assessed by immuno-
blotting (Fig. 3 C), and the production of adenosine was 
monitored by TLC (Fig. 3 A). Lysostaphin extracts of adsA 
mutant staphylococci displayed reduced adenosine synthase 
activity, which could be restored to wild-type levels when adsA 
mutants were transformed with padsA, a plasmid-encoded 
wild-type allele (Fig. 3 A). AdsA harbors 5-nucleotidase 
signature sequences, domains critical for the catalytic activity 
of mammalian enzymes (Zimmermann, 1992). To assess the 
role of adenosine synthase activity toward staphylococcal   
virulence, the YdamaVGNHEFD signature sequence (AdsA 
residues 189–201) was removed to generate AdsA*. Immuno-
blotting revealed the expression of AdsA* in the envelope of 
adsA mutant staphylococci that had been transformed with 
padsA* (Fig. 3 C). Expression of AdsA* restored neither the 
defects in adenosine synthase activity (Fig. 3 A) nor the 
increased clearance of adsA mutant staphylococci in blood 
(Fig.  3  C).  Incubation  of  staphylococci  with  adenosine   
5-(,-methylene) diphosphate (Knöfel and Sträter, 2001), 
a known 5-nucleotidase inhibitor, reduced adenosine pro-
duction and survival of wild-type S. aureus Newman in blood 
(Fig. S2). Collectively, these experiments suggest that AdsA 
adenosine synthase activity may be responsible for the virulence 
attributes of this surface protein.
play a direct role in the formation of abscesses and infectious 
foci. To discern between these possibilities, BALB/c mice 
were infected by intravenous inoculation with 107 CFU and 
peripheral blood was sampled at timed intervals by cardiac 
puncture. In agreement with observations of enhanced clear-
ance of adsA mutant staphylococci in vitro, significantly fewer 
CFUs of adsA mutant staphylococci were retrieved 90 min 
after infection as compared with the wild-type parent strain 
S. aureus Newman (P < 0.05). Transformation of the adsA 
mutant strain with padsA restored its ability to survive in 
blood after intravenous challenge (Fig. 2 E). Although we 
cannot rule out the possibility that adsA also contributes spe-
cifically to abscess formation, these data suggest that the re-
duced virulence of adsA mutant staphylococci results from 
their decreased survival in blood.
5-Nucleotidase activity is the mediator of the virulence 
attributes of AdsA
Given that AdsA harbors a 5nucleotidase signature sequence, 
we asked whether AdsA can synthesize adenosine from AMP. 
Cell-wall peptidoglycan of S. aureus wild type, adsA, and the 
adsA:padsA strain was degraded with lysostaphin (Schindler 
and Schuhardt, 1964), and cell-wall extracts were incubated 
with radiolabeled [14C]AMP. The relative abundance of 
Figure 1.  AdsA, a cell wall–anchored surface protein, is required for staphylococcal survival in blood. Comparison of the survival of 105 CFU of 
wild-type S. aureus Newman (WT) or the isogenic srtA variants in 1 ml of blood from (A) BALB/c mice or (D) Sprague-Dawley rats. Data are the means, and 
error bars represent ± SEM from three independent analyses. To assess the relative contribution of sortase A–anchored cell-wall surface proteins for 
staphylococci survival in blood, isogenic mutants with transposon insertions in the indicated genes were incubated in blood from mice (B) or rats (E) for 
60 min. Expression of padsA rescues staphylococcal survival of an adsA mutant in blood from mice (C), rats (F), or human volunteers (G). 105 CFU of 
staphylococci were incubated with 1 ml of human blood for 0 or 120 min, and Giemsa-stained samples were viewed by microscopy (H). At 0 min, only 
extracellular staphylococci were detected (arrows), whereas after 120 min of incubation staphylococci were mostly associated with neutrophils. The 
abundance of adsA mutants was reduced compared with wild-type staphylococci or adsA mutants harboring the complementing plasmid (padsA). Data 
are representative of three independent analyses with blood from three different human donors. Bars, 10 µm.2420 ADENOSINE ENABLES STAPHYLOCOCCAL ESCAPE FROM IMMUNE RESPONSES | Thammavongsa et al.
MnCl2, similar to the metal requirements of other adenosine 
synthases (Fig. 3 E; Zimmermann, 1992). On the other hand, 
incubation of AdsA with 5 mM ZnCl2 or 5 mM CuSO4 be-
fore the addition of [14C]AMP inhibited adenosine synthase 
activity (Fig. 3 E, lanes 6 and 7). A similar inhibitory effect 
was observed when EDTA, a divalent metal ion chelator, 
was added to the enzyme (Fig. 3 F). AdsA activity appears 
specific  for  adenosine  monophospate,  as  other  nucleotide 
monophosphates were either not cleaved or were cleaved at 
a much reduced rate (Fig. 3 F).
Staphylococcal AdsA synthesizes adenosine during infection
Under physiological conditions, the concentration of AMP in 
the extracellular milieu is estimated to be in the nanomolar 
range. Immunological insult or tissue injury, however, causes 
release of AMP with concentrations up to 100 µM. To us, it 
seemed plausible that these AMP stores may be converted to 
adenosine during staphylococcal infection. To assess the rela-
tive abundance of adenosine during staphylococcal infection, 
1 ml of mouse blood was infected in vitro with 105 CFU   
S. aureus for 60 min. Plasma was recovered by centrifugation, 
protein  was  removed,  and  samples  were  subjected  to  re-
versed-phase HPLC (RP-HPLC). For calibration, we sepa-
rated chemically pure adenosine and determined its molecular 
mass in the eluate (Fig. 4 A). Chromatography of uninfected 
blood revealed the adenosine absorption peak, whose identity 
was confirmed by mass spectrometry (Fig. 4 B). The adenos-
ine peak in blood was increased 10-fold after infection with 
S. aureus Newman (Fig. 4 C), whereas infection with the iso-
genic adsA mutant produced a <2-fold increase in adenosine 
(Fig. 4 D). To examine adenosine production in vivo, mice 
were infected by intravenous inoculation of 107 CFU S. aureus 
and plasma adenosine abundance was quantified 60 min 
after infection. Animals infected with wild-type S. aureus 
Newman (Fig. 4 G) displayed increased amounts of adenosine 
in blood when compared with mice that had been mock in-
fected (Fig. 4 F) or challenged with the adsA variant (Fig. 4 H). 
Thus, in agreement with the conjecture that staphylococci 
synthesize adenosine during infection, both the in vitro and 
the in vivo inoculation of mouse blood with S. aureus Newman 
cause an adsA-dependent increase in adenosine.
Adenosine reduces killing of staphylococci by neutrophils
We hypothesized that staphylococci escape phagocytic clear-
ance in blood by synthesizing adenosine. If so, the survival 
defect of adsA mutant staphylococci in blood should be res-
cued by exogenous supplies of adenosine. This was tested, 
revealing a specific increase in the survival of adsA mutant 
staphylococci in the presence of 5 and 15 µM adenosine   
(Fig. S3) but not with guanosine (Fig. 5 A). We wondered 
whether enhanced growth rates of S. aureus were not ob-
served when adenosine was added to staphylococci incu-
bated in laboratory media (Fig. 5 B), suggesting that the 
ability of adenosine to increase the bacterial load in blood 
may be exerted by its effect on phagocytic cells that other-
wise kill the invading pathogen. In agreement with this 
To characterize the enzymatic activity of AdsA, we expres-
sed a soluble affinity-tagged recombinant form of S. aureus 
AdsA (residues 1–400) in Escherichia coli. Purified AdsA, re-
moved of its affinity tag (Fig. 3 D), cleaved [14C]AMP to 
generate adenosine (Fig. 3 E). Maximal activity (KM = 44 nM) 
was observed in the presence of 5 mM MgCl2 or 5 mM 
Figure 2.  AdsA is a virulence factor that enables staphylococcal 
replication and abscess formation in vivo. Staphylococcal burden in 
kidneys after intravenous challenge of BALB/c mice (n = 10) with (A) 107 
CFU of wild-type S. aureus Newman or its isogenic adsA mutant and (C)  
S. aureus USA300 wild-type or its isogenic adsA mutant was enumerated as 
log10 CFU per gram of tissue 5 d after infection. Data are representative of 
two independent analyses. Microscopic images of hematoxylin-eosin–
stained kidney tissue were obtained after necropsy of mice infected with 
(B) wild-type S. aureus Newman and adsA mutants or (D) wild-type  
S. aureus USA300 and corresponding adsA mutants. Black arrows denote 
the abscess lesions. Data are representative samples of cohorts of five animals 
per bacterial strain and two independent analyses. Bars: (top) 1 mm; (bot-
tom) 100 µm. (E) Staphylococcal burden—wild-type (WT), adsA, or adsA:
padsA S. aureus Newman—in blood of BALB/c mice (n = 10) was measured 
as log10 CFU per 0.5 ml of blood retrieved by cardiac puncture at 30 and  
90 min after intravenous challenge with 107 CFU. Horizontal red bars 
represent mean CFUs in each cohort. Data are representative of three inde-
pendent analyses using cohorts of 10 mice per bacterial strain per time 
point. Unpaired Student’s t tests were used for statistical analysis.JEM VOL. 206, October 26, 2009 
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adsA mutant staphylococci were killed by neutrophils, as the 
GFP fluorescence of GR1-positive cells declined over time 
(Fig. 5 D and Fig. S5). In contrast, GFP fluorescence of wild-
type staphylococci within neutrophils was not diminished 
(Fig. 5 D). GFP fluorescence could not be identified in iso-
lated monocytes and T or B lymphocytes of infected mouse 
blood,  suggesting  that  C3b  deposition  primarily  triggers 
staphylococcal phagocytosis by neutrophils (Fig. S4). Phago-
cytosis is thought to play a dominant role in the clearance of 
S. aureus from blood. Cytochalasin D, a molecule that inhib-
its actin polymerization, is known to block phagocytosis   
(Casella et al., 1981). In some cell types, e.g., macrophages, 
cytochalasin D can also inhibit the binding of yeast particles 
to complement-independent phagocytic receptors (Bos and 
de Souza, 2000). In our assay, where GFP-expressing staphy-
lococci are taken up by neutrophils, 10 µM cytochalasin D 
inhibited  phagocytosis  and  increased  the  survival  of  both 
wild-type and adsA mutant staphylococci (Fig. S7).
B. anthracis survives in blood and synthesizes adenosine
To  investigate  whether  other  pathogenic  bacteria  express 
adenosine synthases, we first examined bacterial genome se-
quences with BLAST searches for predicted translation prod-
ucts harboring the adenosine synthase domain of AdsA; 
homologues  were  identified  in  several  different  species 
hypothesis, no difference in bacterial survival or growth was 
observed  when  wild-type  and adsA  mutant  staphylococci 
were incubated in human serum or plasma (Fig. 5 C).
Although many different antimicrobial factors have been 
revealed in blood, PMNs, particularly phagocytic neutro-
phils, play a dominant role in innate immune defenses against 
staphylococci (Verdrengh and Tarkowski, 1997; Mölne et al., 
2000; Voyich et al., 2005). To ascertain the fate of staphylo-
cocci in blood, we incubated S. aureus Newman expressing 
GFP in anticoagulated blood and measured bacterial phago-
cytosis and clearance by immune cells (Fig. 5 D). To distin-
guish extracellular from intracellular bacteria, blood and cell 
samples were treated with lysostaphin, a glycyl-glycine endo-
peptidase that quickly lyses extracellular staphylococci and 
abrogates GFP fluorescence (Fig. S4). Blood samples were 
stained with anti-GR1 and infected neutrophils were ana-
lyzed by flow cytometry (Fig. S5). 15 min after staphylococ-
cal  inoculation  into  blood,  neutrophils  had  internalized 
similar numbers of lysostaphin-resistant wild-type and adsA 
mutant staphylococci, measured as GFP fluorescence of 
GR1-positive cells (Fig. 5 D and Fig. S5). Staphylococcal 
uptake involves neutrophil opsonophagocytosis, which is not 
affected by adenosine synthesis, as similar amounts of C3b 
were found deposited on the surface of wild-type and adsA 
mutant staphylococci (Fig. S6). Upon 30 min of incubation, 
Figure 3.  5-Nucleotidase activity of AdsA is essential for virulence. (A) Lysostaphin-generated cell-wall extracts of staphylococcal strains were 
incubated with radiolabeled [14C]AMP. The generation of [14C]adenosine ([14C]Ado) was measured by TLC using a PhosphorImager (Storm; GE Healthcare). 
Data are representative of two independent analyses. (B) S. aureus strains in A were analyzed for their ability to survive in lepirudin-anticoagulated fresh 
blood obtained from BALB/c mice. Data are representative of two independent analyses conducted in triplicate; error bars represent the SEM. (C) The 
abundance of AdsA in cell-wall lysates was measured by immunoblotting analyses with anti-AdsA rabbit polyclonal sera. The following strains were 
tested: S. aureus Newman wild-type (WT), adsA, adsA:padsA (harboring the padsA plasmid for the expression of wild-type adsA), and adsA:padsA* (har-
boring the padsA* plasmid for the expression of an adsA variant lacking the 5-nucleotidase signature sequence. The arrow denotes protein A immuno-
reactive signals. Data are representative of four independent analyses (D) Recombinant GST-AdsA was purified from E. coli and cleaved with thrombin to 
generate AdsA1-400, and purified proteins were analyzed by Coomassie-stained SDS-PAGE. Data are representative of five independent analyses. (E) Radio-
labeled [14C]AMP was incubated in the presence or absence of 2 µM of purified AdsA1-400 and in the presence or absence of 5 mM of various metal 
ions. Radioactive signals for [14C]AMP and [14C]Ado after TLC were captured by a PhosphorImager. Data are representative of six independent analyses. 
(F) Radiolabeled [14C]AMP (lanes 1–4), [14C]GMP (lanes 5–8), [14C]CMP (lanes 9–12), and [14C]TMP (lanes 13–16) were incubated in the presence or absence 
of 2 µM of purified AdsA1-400 in the presence or absence of 5 mM of various metal ions, as indicated. Radioactive signals for [14C]xMP (nucleotide mono-
phosphate) and [14C]nucleotide free base after TLC were captured by a PhosphorImager. Data are representative of three independent analyses.2422 ADENOSINE ENABLES STAPHYLOCOCCAL ESCAPE FROM IMMUNE RESPONSES | Thammavongsa et al.
peptidoglycan (Yokogawa et al., 1974), was used to generate 
cell-wall lysates. Cell-wall extracts of wild-type bacilli har-
bored adenosine synthase activity, whereas extracts derived 
from adsA mutant bacilli displayed reduced activity (Fig. 6 A). 
Deletion of the structural gene adsA abolished the expression 
of adenosine synthase (Fig. 6 B), abrogated the surface dis-
play of AdsA by B. anthracis (Fig. 6 C), and reduced the abil-
ity of bacilli to synthesize adenosine (Fig. 6 A). Residual 
amounts of AMP hydrolysis are attributed to other phospha-
tases, including alkaline phosphatase. We expressed and af-
finity tagged B. anthracis AdsA in E. coli and purified the 
enzyme. Similar to S. aureus AdsA, adenosine synthase activ-
ity of B. anthracis AdsA was observed in the presence of 5 mM 
(Table S1). For example, the genome of B. anthracis encodes 
an AdsA homologue (B. anthracis surface protein; available 
from GenBank/EMBL/DDBJ under accession no. BAS4031) 
with  a  5-nucleotidase  signature  sequence  (YdvisLGN-
HEFN; residues 131–142), an N-terminal signal peptide, and 
a C-terminal LPXTG sorting signal, indicating that this sur-
face protein is also deposited by sortase A in the cell-wall en-
velope (Gaspar et al., 2005). To determine whether B. 
anthracis AdsA functions as an adenosine synthase and con-
tributes to escape from innate immune responses, we con-
structed  a  deletion  mutant  of  B.  anthracis  adsA  by  allelic 
replacement (Fig. 6). Mutanolysin, a muralytic enzyme that 
cleaves N-acetylmuramyl-(1→4)-N-acetylglucosamine within 
Figure 4.  S. aureus AdsA synthesizes adenosine in blood. (A) RP-HPLC 
to quantify 100 µM adenosine (left) and identify its monoisotopic ions by 
MALDI-MS (right). 1 ml of lepirudin-anticoagluated mouse blood was incu-
bated without (B) or with 105 CFU of wild-type S. aureus Newman (WT; C) 
or its isogenic adsA variants (D) for 1 h. Plasma was deproteinized, filtered, 
and subjected to RP-HPLC to quantify adenosine (left) and identify its mo-
noisotopic ions by MALDI-MS (right). Arrows denote corresponding adenos-
ine peaks. Calculated abundance of adenosine in plasma extrapolated from 
the purified adenosine control was 1.1 µM (B, no staphylococci), 13.2 µM  
(C, WT S. aureus Newman), and 2.1 µM (D, adsA mutant staphylococci). Data 
are representative of three independent analyses. (E–H) RP-HPLC analyses 
of 50 µM adenosine (E) or plasma collected from mice that had been mock 
infected (F), or from animals that were challenged with 107 CFU wild-type 
(WT; G) or (H) adsA mutant bacteria. Data are representative of two inde-
pendent analyses. The calculated abundance of plasma adenosine in mice 
extrapolated from the purified adenosine control was 2.8 ± 0.6 µM (F, no 
staphylococci), 16.4 ± 2.1 µM (G, WT S. aureus Newman), and 7.4 ± 3.2 µM 
(H, adsA mutant staphylococci). mAU, milliabsorbance units of HPLC eluate.
Figure 5.  Immunosuppressive effects of adenosine contribute to 
S. aureus survival in blood. (A) Survival of adsA S. aureus Newman in 
mouse blood in the presence of increasing concentrations of adenosine 
(left) or guanosine (right) as indicated. Extracellular adenosine concentra-
tion was quantified by RP-HPLC immediately before enumerating bacterial 
CFUs, as described in Fig. S3. Data are representative of two independent 
analyses conducted in duplicate (left) and are representative of five inde-
pendent analyses (right); error bars represent the SEM. (B) Growth of wild-
type and adsA S. aureus Newman in laboratory growth media with 0–500 µM 
adenosine (Ado) for 15 and 45 min. Data are means of two independent 
analyses conducted in triplicate. Error bars represent the SEM. (C) Survival 
of wild-type, adsA, or adsA:padsA S. aureus Newman in human plasma. 
Data are averaged of two independent analyses conducted in triplicate; 
error bars indicate SEM. (D) The adsA gene is required for staphylococcal 
escape from neutrophil killing. Mouse blood was inoculated with S. aureus 
Newman expressing GFP, comparing the wild type (WT) and its isogenic 
adsA variant. At the indicated time points, samples were treated with  
10 µg/ml1 lysostaphin, followed by isolation of neutrophils by FACS using 
anti-GR1 staining and phagocytosis and survival of staphylococci mea-
sured as mean GFP fluorescence. Data are representative of two indepen-
dent analyses conducted in triplicate; error bars indicate SEM.JEM VOL. 206, October 26, 2009 
ARTICLE
2423
cell-wall extracts derived from Enterococcus faecilis and S. epi-
dermidis both synthesized adenosine from AMP, but B. subti-
lis did not (Fig. 7). The B. subtilis chromosome encodes a 
gene with a 5-nucleotidase signature motif (Kunst et al., 
1997); however, it is currently not known whether or not 
this gene is expressed and its predicted product displays activ-
ity. Nevertheless, we surmise that the ability of bacterial 
pathogens to synthesize adenosine and release this immuno-
suppressive compound may represent an important virulence 
strategy in many different hosts.
DISCUSSION
This study provides evidence that S. aureus and other bacte-
rial pathogens generate adenosine to promote their survival 
during host infection. We identified and characterized AdsA, 
a cell wall–anchored protein of S. aureus with 5-nucleotidase 
signature sequences, and its functional homologue in B. an-
thracis. We show that adsA is required for synthesis of adenos-
ine during infection and that the structural gene contributes 
to the survival of S. aureus and B. anthracis in animal or hu-
man blood. Further, in a renal abscess model of S. aureus in-
fection in mice, adsA was required for pathogen replication 
in organ tissues and for the formation of abscess lesions.
5-Nucleotidases are present in many different bacterial 
species, but their potential as virulence factors has hitherto 
not been appreciated. We provide evidence that AdsA may 
be a clinically relevant virulence factor of CA-MRSA strain 
USA300, the causative agent of the majority of community-
acquired skin and soft-tissue infections in the United States 
(Carleton et al., 2004). Roche et al. (2003) previously re-
ported that sasH (adsA) was significantly associated with in-
vasive disease isolates as compared with nasal carriage isolates, 
further distinguishing a pivotal role for adsA in staphylococ-
cal disease. Although the extraordinary immunosuppressive 
attributes of adenosine are generally known, to the best of 
our knowledge, this study provides the first mechanistic link 
MnCl2 (KM = 2.01 nM), whereas 5 mM MgCl2 reduced its 
activity (Fig. 6 D). When inoculated into mouse blood, we 
observed increased phagocytic clearance of the adsA mutant, 
as compared with the wild-type parent B. anthracis Sterne 
(Fig. 6 E). Collectively, these experiments suggest that B. an-
thracis also utilizes AdsA to synthesize adenosine and escape 
host innate immune responses.
Several  other  Gram-positive  bacteria  harbor  putative   
5-nucleotidase genes (Table S1), and we analyzed their ability 
to synthesize adenosine. Similar to S. aureus and B. anthracis, 
Figure 6.  5-Nucleotidase activity of AdsA enhances B. anthracis 
survival in blood. (A, top) Mutanolysin extracts from B. anthracis strain 
Sterne (WT) or its isogenic adsA variant were incubated with radiolabeled 
[14C]AMP. The generation of adenosine was measured by TLC. (bottom) 
Quantification of relative abundance of adenosine. Data are the mean of 
three independent analyses; error bars indicate SEM. (B) Mutanolysin 
extracts were analyzed by immunoblotting with antibodies directed 
against B. anthracis AdsA or BasC (anti-BasC), a control protein not in-
volved in adenosine production. Bars, 5 µm. (C) Fluorescence microscopy 
images of wild-type B. anthracis Sterne and its isogenic adsA mutant 
stained with antiserum against B. anthracis AdsA (top) or nonreactive 
serum (NRS) and Cy3-labeled secondary antibodies (red), as well as 
Hoechst staining of nucleic acids (blue). Data are representative of two 
independent analyses. (D) Radiolabeled [14C]AMP was incubated with  
2 µM of purified B. anthracis AdsA in the presence of 5 mM of the indi-
cated metal cations, and generation of [14C]adenosine ([14C]Ado) was 
measured by TLC and a PhosphorImager. Data are representative of three 
independent analyses. (E) Survival of wild-type and adsA B. anthracis 
Sterne in rat blood over time, measured as CFUs on agar plates. Data are 
the mean of two independent analyses; error bars indicate SEM.
Figure 7.  Hydrolysis of AMP is observable in various Gram-positive 
pathogens. (A) Cell-wall proteins from the indicated bacterial strains were 
released with mutanolysin digestion, and mutanolysis extracts were incu-
bated with radiolabeled [14C]AMP. Hydrolysis of AMP into adenosine was 
assessed by separating the compounds by TLC. (B) Quantification of the 
relative abundance of adenosine produced in cell-wall extracts from A. Data 
represent the mean of three independent analyses; error bars indicate SEM.2424 ADENOSINE ENABLES STAPHYLOCOCCAL ESCAPE FROM IMMUNE RESPONSES | Thammavongsa et al.
Trichinella spiralis parasites (Gounaris, 2002) and Vibrio chol-
erae, a Gram-negative pathogen (Punj et al., 2000). Collec-
tively, our results suggest that S. aureus and other Gram-positive 
pathogens increase extracellular concentrations of the potent 
immunosuppressive  molecule  adenosine  and,  through  this 
mechanism, are likely able to perturb immune defenses and 
promote their survival in host tissues.
MATERIALS AND METHODS
Bacterial strains. S. aureus strains were grown in TSB at 37°C. S. aureus 
strain USA300 was obtained through the Network on Antimicrobial Resis-
tance in Staphylococcus aureus (National Institute of Allergy and Infectious 
Diseases [NIAID]). All mutants used in this study were obtained from the 
Phoenix (N) library (Bae et al., 2004). Each Phoenix isolate is a deriva-
tive of the clinical isolate Newman (Duthie and Lorenz, 1952) or USA300   
(Carleton et al., 2004), as indicated in the figures. All bursa aurealis insertions 
were transduced into wild-type S. aureus Newman or USA300 using bacte-
riophage 85 and verified by PCR analysis. Chloramphenicol was used at   
10 mg/liter1 for plasmid and allele selection with padsA. Erythromycin was 
used at 10 mg/liter1 for allele selection in S. aureus Newman and at 50 mg/
liter1 for allele selection in USA300. Mutants of B. anthracis strain Sterne 
were generated with pLM4, containing a thermosensitive origin of replica-
tion. Plasmids with a 1-kb DNA sequence flanking each side of the mutation 
were transformed into B. anthracis, and transformants were grown at 30°C 
(permissive temperature) in Luria broth (LB; 20 µg/ml1 kanamycin). Cul-
tures were diluted 1:100 and plated on LB agar (20 µg/ml1 kanamycin) at 
43°C overnight (restrictive temperature). Single colonies were inoculated 
into LB broth without antibiotics and grown overnight at 30°C. To ensure 
loss of pLM4-based plasmid, these cultures were diluted four times into fresh 
LB broth without antibiotic pressure and propagated at 30°C. Cultures were 
diluted and plated on LB agar and colonies were examined for kanamycin 
resistance. DNA from kanamycin-sensitive colonies was analyzed by PCR 
for the presence or absence of mutant alleles.
S. aureus–expressing GFP. Plasmid pTetPro-GFP, a pCL55 derivative with 
a tetracycline-inducible promoter, was electroporated into S. aureus TB9 to 
generate TB9 (tetPro-gfp). TB9 is a variant of S. aureus Newman generated by 
homologous recombination to excise bacteriophage NM4 from the geh li-
pase gene (Bae et al., 2006). pTetPro-GFP integration into the geh gene re-
sulted in a lipase-negative phenotype, which was verified on egg-yolk plates.
Plasmids. The following primers were used for PCR amplification reactions: 
P55 (5-TTTCCCGGGACGATCCAGCTCTAATCGCTG-3), P56 (5-TTT-
GAGCTCAAAGCAAATAGATAATCGAGAAATATAAAAAG-3),  P57 
(5-TTTGAGCTCAGTTGCTCCAGCCAGCATT-3), mP58 (5-TTT-
GAATTCAAACGGATTCATTCCAGCC-3), FP10 (5-TACGAATTCG-
ACTTGGCAGGCAATTGAAAA-3), RP10 (5-TGTGAATTCTTAG-
CTAGCTTTTCTACGTCG-3), FP3C (5-TCGGGATCCGCTGAGCA-
GCATACACCAATG-3), RPB (5-TGTGGATCCTTATTGATTAATT-
TGTTCAGCTAATGC-3), VTFD (5-TACAGATCTTTTGGATACGAT-
CAGTTG-3), VTRC (5-TACAGATCTATAACCTACTGCATTCAT-3), 
#184 (5-CGGGATCCCCTCGAGTTCATGAAAAAC-3), and #192 
(5-GGGGTACCTTATTTGTATAGTTCATCCATGCCATGTG-3).   
Ligation of FP10/RP10 (adsA + 700 bp upstream from start site) PCR products 
into  pOS1  (EcoRI)  generated  padsA.  Triple  ligation  of  FP10/VTRD  and 
VTFD/RP10 (deletion of amino acids 189–201) PCR products into pOS1 
(EcoRI) generated padsA. Insertion of P55/P56 (basA 1-kb 5 flanking se-
quence) and P57/P58 (basA 1-kb 3 flanking sequence) PCR products into 
pLM4 (EcoRI, SacI, and XmaI sites) generated pJK34. This plasmid was used to 
delete the basA coding sequence. Ligation products were transformed into E. coli 
DH5, and plasmid DNA was transformed into E. coli K1077 (dam, dcm), and 
purified (nonmethylated) plasmid DNA was transformed into B. anthracis ac-
cording to a previously developed protocol (Gaspar et al., 2005). Ligation of 
FP3C/RPB (1.2-kb truncation of adsA starting 5 after the signal peptide) PCR 
between  bacterial  pathogenesis  and  adenosine  synthesis.   
S. aureus is primarily an extracellular pathogen, and the main 
thrust of host defenses against this pathogen relies on PMNs 
and phagocytic killing (Lowy, 1998). Adenosine is known to 
inhibit neutrophil degranulation (Bouma et al., 1997), adhe-
sion to vascular surfaces (Firestein et al., 1995), and superox-
ide burst (Cronstein et al., 1990; Gunther and Herring, 1991; 
Kaufmann et al., 2007). Our experiments reveal the effect of 
adenosine on staphylococcal survival in blood at an early 
stage of infection (30–90 min), when tissue damage and 
AMP release is limited. At a later stage of infection, when S. 
aureus seeds abscesses and causes liquefaction necrosis, AMP 
levels are expected to increase as a consequence of staphylo-
coccal toxins, e.g., -hemolysin, leukocidins, or phenol-sol-
uble modulins, that form pores in membranes and precipitate 
cellular lysis (Diep and Otto, 2008).
We observed further that adsA-deficient S. aureus were 
cleared more rapidly from the bloodstream of BALB/c mice 
than wild-type staphylococci, correlating with the reduced 
ability to grow during infection and/or seed abscesses; pre-
sumably, lower numbers of adsA mutant staphylococci can 
disseminate through the vasculature and form abscess lesions.
In addition to neutrophils, tissue macrophages are essen-
tial for the clearance of bacterial infections. Adenosine di-
rectly impairs the ability of macrophages to combat infection 
by decreasing the phagocytic activity of these cells (Eppell   
et al., 1989). Further, adenosine attenuates macrophage anti-
bacterial activity by suppressing the production of superoxide 
(Edwards et al., 1994) and nitric oxide (Haskó et al., 1996; 
Xaus et al., 1999), both of which are integral to the killing of 
phagocytosed bacteria. Macrophage deactivation by adenos-
ine also suppresses antibacterial defense mechanisms by de-
creasing the production of proinflammatory cytokines that 
both orchestrate inflammatory/immune functions of other 
cell types and act as regulators of macrophage function (Haskó 
and Szabó, 1998). For example, TNF is a regulator of neu-
trophil, endothelial cell, and lymphocyte function, and the 
production of TNF has been shown to be under negative 
control of adenosine. Finally, an important consideration is 
that adenosine, through the activation of macrophages, may 
decrease T cell antibacterial effector mechanisms. In support 
of this conjecture, adenosine decreases the expression of 
MHC II on macrophages (Edwards et al., 1994) and den-
dritic cells (Panther et al., 2001), and it decreases macrophage 
production of IL-12, a pivotal stimulus for Th1-type immune 
responses (Haskó et al., 2000).
Examination of the genomes of Gram-positive bacteria 
identified genes with similarities to putative 5-nucleotidases. 
Many of these proteins harbor sortase A–specific sorting sig-
nals (LPXTG), indicating that their mature products are lo-
calized in the bacterial cell-wall envelope. Such localization 
appears  relevant,  as  surface-exposed  adenosine  synthases 
should release their product in close proximity to phagocytic 
cells. Other microorganisms secrete 5-nucleotidases into   
the extracellular environment, as recent studies have described   
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plate, followed by separation by TLC using a (75:25 isopropanol/double-
distilled H2O) 0.2-M ammonia bicarbonate solvent. For cell-wall extracts of 
S. aureus, E. faecilis, B. anthracis, and S. epidermidis digested with mutanolysin, 
mutanolysin was substituted for lysostaphin and used according to the man-
ufacturer’s recommended conditions. When assayed with purified proteins, 
2 µM of purified AdsA or BasA was incubated in a final volume of 15 µl 
with 3 µCi [14C]AMP in the presence of the metal cations in TSM buffer 
indicated in the figures.
Adenosine  concentration  in  blood.  Whole-blood  killing  assay  with 
staphylococci was performed as described in Bacterial survival in blood. Ex-
traction of plasma was performed as previously described (Mo and Ballard, 
2001). In brief, after conclusion of the whole-blood killing assay, blood sam-
ples were centrifuged at 16,000 g for 5 min and noncellular plasma was col-
lected. 600 µl of plasma was extracted with 75 µl perchloric acid (1.5 M) and 
1 mM EDTA. The 500-µl supernatant was withdrawn after centrifugation 
for 5 min at 16,000 g and neutralized with 29 µl of 4 M KOH. After ice 
cooling for 10 min, the sample was again centrifuged at 16,000 g for 5 min. 
The pH of the supernatant was finally adjusted to pH 6–7, diluted 1:4 with 
PBS, and filtered with a 0.22-µm syringe filter before RP-HPLC.
HPLC and mass spectrometry. The presence of adenosine production 
was determined by RP-HPLC. Samples were chromatographed on a   
250 mm × 3 mm column (5-µm particle size; BDS Hypersil C18; Thermo 
Fisher  Scientific).  The  mobile  phase  consisted  of  solution  A  (deionized 
H2O/0.1% trifluoroacetic acid) and solution B (acetonitrile/0.1% trifluoro-
acetic acid). Adenosine was eluted with a solvent B gradient from 1 to 100%, 
run from 5 to 50 min. The solvent flow rate was 0.5 ml/min. Peaks were 
detected by their UV absorbance at 260 nm. The peak of adenosine in the 
HPLC chromatogram was identified by comparison of its retention time to 
the retention time of purified adenosine used as a standard sample. Fractions 
containing adenosine were cospotted with matrix (-cyano-4-hydroxycin-
namic acid) and subjected to matrix-assisted laser desorption/ionization–mass 
spectrometry (MALDI-MS) under reflector-positive conditions.
FACS analyses. Freshly prepared mouse blood was inoculated with S. au-
reus Newman expressing GFP and incubated at 37°C as described. Aliquots 
were removed and incubated for an additional 5 min with 10 µg/ml1 lyso-
staphin. After lysostaphin treatment, samples were diluted with ice cold PBS 
plus 10 µM cytochalasin D, and erythrocytes were lysed with erythrocyte ly-
sis buffer (QIAGEN) for 30 min on ice. Blood leukocytes were washed three 
times by centrifuging at 400 g, and cells were suspended in PBS/1% FBS. 
Cells  were  stained  with  allophycocyanin-conjugated  anti-GR1  or  anti-
F4/80 antibodies, or PE-conjugated anti-CD4, anti-CD8, or anti-B220 an-
tibodies (eBioscience), and analyzed using a FACSCanto (BD).
Online supplemental material. Fig. S1 examines the contribution of 
adsA toward S. aureus USA300 abscess formation in mice. Fig. S2 docu-
ments that adsA-mediated adenosine production is responsible for enhanced 
survival of staphylococci in blood and that this phenotype can be inhibited 
with adenosine 5-(,-methylene) diphosphate. The rapid clearance of 
exogenously added adenosine in blood is studied in Fig. S3. Fig. S4 exam-
ines the correlation between GFP fluorescence of staphylococci and bacte-
rial viability in the presence of lysostaphin. Fig. S5 displays representative 
FACS dot plots and histograms demonstrating that wild-type and adsA mu-
tant staphylococci are phagocytosed by neutrophils, but that only adsA mu-
tants, not the wild type, are killed by immune cells. Fig. S6 analyzes the 
deposition of complement (C3b) on the staphylococcal surface in the pres-
ence or absence of AdsA. Fig. S7 uses cytochalasin D to study the contribu-
tion of phagocytosis toward staphylococcal killing by neutrophils. Table S1 
lists Gram-positive bacteria encoding AdsA homologues, which are an-
chored to the cell-wall envelope. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20090097/DC1.
We thank members of our laboratory, F. Bagnoli, and G. Grandi for critical 
comments and discussion.
products into pGEX-2T (GE Healthcare) generated the adsA expression vector 
pVT1, and this plasmid was transformed into E. coli BL21. Ligation of PCR am-
plification products generated with primers #184/#192 into pCL55 (Lee et al., 
1991) using BamHI/KpnI sites resulted in plasmid pTetPro-GFP (Gründling and 
Schneewind, 2007).
Animal  experiments.  All  experimental  protocols  were  reviewed,  ap-
proved, and performed under regulatory supervision of the University of 
Chicago’s Institutional Biosafety Committee and Institutional Animal Care 
and Use Committee. BALB/c mice were purchased from Charles River, and 
Sprague-Dawley rats were purchased from Harlan. Overnight cultures of 
S. aureus strains were diluted 1:100 into fresh TSB and grown for 3 h at 37°C. 
Staphylococci were centrifuged, washed twice, and diluted in PBS to yield 
an OD600 of 0.5 (108 CFU ml1). Viable staphylococci were enumerated by 
colony formation on tryptic soy agar plates to quantify the infectious dose. 
Mice were anaesthetized by intraperitoneal injection of 80–120 mg ketamine 
and 3–6 mg xylazine per kilogram of body weight. 100 µl of bacterial suspen-
sion (107 CFU) was administered intravenously via retroorbital injection into 
6-wk-old female BALB/c mice. On day 5, mice were killed by compressed 
CO2 inhalation. Kidneys were removed and homogenized in PBS contain-
ing 1% Triton X-100. Aliquots of homogenates were diluted and plated on 
agar medium for triplicate determination of CFUs. The Student’s t test was 
performed for statistical analysis using Prism software (GraphPad Software, 
Inc.). For histopathology, kidney tissue was incubated at room temperature 
in 10% formalin for 24 h. Tissues were embedded in paraffin, thin sectioned, 
stained with hematoxylin-eosin, and examined by microscopy.
To measure staphylococcal survival in blood, 6-wk-old female BALB/c 
mice were infected with 107 CFU of staphylococci by retroorbital injection. 
At 30 or 90 min, mice were killed by compressed CO2 inhalation and blood 
was collected by cardiac puncture using a 25-gauge needle. Aliquots were 
incubated on ice for 30 min in a final concentration of 0.5% saponin/PBS to 
lyse host eukaryotic cells. Dilutions were plated on TSA for enumeration of 
surviving CFUs at the two different time points.
Chemicals. Mutanolysin (Sigma-Aldrich) was suspended at a concentration 
of 5,000 U/ml1 in 100 mM sodium phosphate, pH 6, containing 1 mM 
PMSF and stored at 20°C. [14C]AMP, [14C]GMP, [14C]CMP, [14C]TMP, 
and  [14C]adenosine  were  purchased  from  Moravek  Biochemicals.  Lyso-
staphin was purchased from AMBI and purified adenosine was purchased 
from Sigma-Aldrich.
Bacterial survival in blood. Overnight cultures of S. aureus strains were 
diluted 1:100 into fresh TSB and grown for 3 h at 37°C. Staphylococci were 
centrifuged, washed twice, and diluted in PBS to yield an OD600 of 0.5   
(108 CFU/ml1). Whole blood was collected by cardiac puncture of Sprague-
Dawley rats or BALB/c mice, and 5 µg/ml1of lepirudin anticoagulant was 
immediately added. 100 µl of 106 CFU/ml1 of bacteria were mixed with 
900 µl of rat or mouse blood. For human blood studies, 100 µl of 108 CFU/ml1 
of bacteria was mixed with 900 µl of freshly drawn human blood. The tubes 
were incubated at 37°C with slow rotation for the time points indicated in 
the figures, at which time aliquots were incubated on ice for 30 min in a final 
concentration of 0.5% saponin/PBS to lyse eukaryotic cells. Dilutions of 
staphylococci were plated on TSA for enumeration of surviving CFUs. Ex-
periments with blood from human volunteers involved protocols that were 
reviewed,  approved,  and  performed  under  regulatory  supervision  of  the 
University of Chicago’s Institutional Review Board.
Adenosine synthase activity. Overnight cultures of S. aureus strains were 
diluted 1:100 into fresh TSB and grown for 3 h at 37°C. Staphylococci were 
centrifuged and washed twice with PBS. 3 ml of cells was spun down and 
suspended in 100 µl TSM buffer (50 mM Tris-HCL [pH 7.5], 10 mM 
MgCl2, and 0.5 M sucrose); lysostaphin (final concentration = 70 µg/ml1) 
was added and allowed to incubate for 30 min at 37°C. The solution was 
spun down for 5 min at 9,000 g, and supernatants containing released cell-
surface proteins were collected. 15 µl of lysostaphin extracts were incubated 
with 3 µCi [14C]AMP for 30 min at 37°C. Samples were spotted on a silica 2426 ADENOSINE ENABLES STAPHYLOCOCCAL ESCAPE FROM IMMUNE RESPONSES | Thammavongsa et al.
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